In summary, PD is characterized by a significant reduction in neuroprotective and antioxidant biomarkers (SIRT1 and Nrf2) alongside elevated inflammatory activity (NLRP3), which collectively contribute to fatigue, diminished activities of daily living, and impaired health-related quality of life. Here, NLRP3 is linked to Parkinson disease.